90 related articles for article (PubMed ID: 32674353)
21. Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data.
Giovinazzo F; Soggiu F; Jang JY; Versteijne E; van Tienhoven G; van Eijck CH; Han Y; Choi SH; Kang CM; Zalupski M; Ahmad H; Yentz S; Helton S; Rose JB; Takishita C; Nagakawa Y; Abu Hilal M
Front Oncol; 2020; 10():1112. PubMed ID: 32850319
[No Abstract] [Full Text] [Related]
22. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
23. Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice.
Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Mar; 37(3):1005-1011. PubMed ID: 28314258
[TBL] [Abstract][Full Text] [Related]
24. Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing.
Kleinerman ES; Yu L; Dao J; Hayes-Jordan AA; Lindsey B; Kawedia JD; Stewart J; Gordon N
Sarcoma; 2018; 2018():3143096. PubMed ID: 29610563
[TBL] [Abstract][Full Text] [Related]
25. Lung cells support osteosarcoma cell migration and survival.
Yu S; Fourman MS; Mahjoub A; Mandell JB; Crasto JA; Greco NG; Weiss KR
BMC Cancer; 2017 Jan; 17(1):78. PubMed ID: 28122543
[TBL] [Abstract][Full Text] [Related]
26. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation.
Zhang Y; Zhang GL; Sun X; Cao KX; Ma C; Nan N; Yang GW; Yu MW; Wang XM
Oncol Lett; 2018 May; 15(5):6233-6240. PubMed ID: 29616105
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines.
Buchy E; Vukosavljevic B; Windbergs M; Sobot D; Dejean C; Mura S; Couvreur P; Desmaële D
Beilstein J Org Chem; 2016; 12():1127-35. PubMed ID: 27559365
[TBL] [Abstract][Full Text] [Related]
29. State of the art in pediatric nanomedicines.
Abedin S; Adeleke OA
Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38324166
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy.
Pereira-Silva M; Miranda-Pastoriza D; Diaz-Gomez L; Sotelo E; Paiva-Santos AC; Veiga F; Concheiro A; Alvarez-Lorenzo C
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258105
[TBL] [Abstract][Full Text] [Related]
31. Recent and Ongoing Research into Metastatic Osteosarcoma Treatments.
Harris MA; Hawkins CJ
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409176
[TBL] [Abstract][Full Text] [Related]
32. Bone Marrow Mesenchymal Stem Cells-Derived Extracellular Vesicles Promote Proliferation, Invasion and Migration of Osteosarcoma Cells via the lncRNA MALAT1/miR-143/NRSN2/Wnt/β-Catenin Axis.
Li F; Chen X; Shang C; Ying Q; Zhou X; Zhu R; Lu H; Hao X; Dong Q; Jiang Z
Onco Targets Ther; 2021; 14():737-749. PubMed ID: 33564242
[TBL] [Abstract][Full Text] [Related]
33. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
[TBL] [Abstract][Full Text] [Related]
34. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.
Maksimenko A; Alami M; Zouhiri F; Brion JD; Pruvost A; Mougin J; Hamze A; Boissenot T; Provot O; Desmaële D; Couvreur P
ACS Nano; 2014 Mar; 8(3):2018-32. PubMed ID: 24555414
[TBL] [Abstract][Full Text] [Related]
36. Progress in the chemotherapeutic treatment of osteosarcoma.
Zhang Y; Yang J; Zhao N; Wang C; Kamar S; Zhou Y; He Z; Yang J; Sun B; Shi X; Han L; Yang Z
Oncol Lett; 2018 Nov; 16(5):6228-6237. PubMed ID: 30405759
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma.
Rodríguez-Nogales C; Moreno H; Zandueta C; Desmaële D; Lecanda F; Couvreur P; Blanco-Prieto MJ
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674353
[TBL] [Abstract][Full Text] [Related]
38. Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.
Rodríguez-Nogales C; Mura S; Couvreur P; Blanco-Prieto MJ
Int J Pharm; 2020 May; 582():119345. PubMed ID: 32311470
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
